News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Blue and white graphic with hexagonal pattern, "Funding Opportunity Available"

Apply by February 13 for Supplemental Funds to Support Data Science Training

You can use the funding to support data science training related to research on infectious- and immune-mediated disease, including cancer.

Text on blue background with small blue dots. Text reads, "Funding Opportunity."

Apply by February 3 for Project Funding to Enhance NIH Common Fund Data Sets

The NIH Common Fund wants to enhance the value and use of its programs’ data sets. One of these programs—the Gabriella Miller Kids First Program—is designed for making discoveries in childhood cancers and birth defects. If you have a project that needs funding and could help enhance such data sets, submit an application by February 3, 2023.

Figure shows CT scans and corresponding 3-D renderings of tumor vasculature for people who responded to therapy vs. those who didn't. Tumor vasculature in non-responders had more twists and turns than those who responded to treatment.

Tumor Twistedness Serves as AI-Based Biomarker for Lung Cancer Immunotherapy

Using data from routine lung scans, NCI-supported researchers developed an AI-based tool to help predict how patients will respond to therapy.

Closeup of the word 'data' in a dictionary.

Winter 2022 Updates to Semantic Products of NCI Enterprise Vocabulary Services

The latest release from NCI’s Enterprise Vocabulary Services includes updates to SeroNet terminology, childhood neoplasm terminologies, as well as other standalone terminologies, ontologies, and mappings.

Text reads, "Funding Opportunity," overlaid on a blue and grey-scale repeating triangular pattern.

Apply to Provide Statistical and Data Management Support to the NCI Cancer Screening Research Network

This new cancer screening research network will require a team that can lead data management, quality control, and reporting activities of its clinical trials and studies. To be that team, apply as soon as January 28 but no later than February 28, 2023!

SUBSCRIBE TO UPDATES

Categories

Archive